117 results on '"Rutter, Joni L."'
Search Results
2. From Alpha to Omicron and Beyond: Associations Between SARS-CoV-2 Variants and Surgical Outcomes
3. The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative
4. The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseases
5. Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study
6. Nonelective coronary artery bypass graft outcomes are adversely impacted by Coronavirus disease 2019 infection, but not altered processes of care: A National COVID Cohort Collaborative and National Surgery Quality Improvement Program analysis
7. Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
8. Thirty-Day Mortality and Complication Rates in Total Joint Arthroplasty After a Recent COVID-19 Diagnosis: A Retrospective Cohort in the National COVID Cohort Collaborative (N3C)
9. Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19: A Retrospective Cohort Study*
10. COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry
11. Risk for stillbirth among pregnant individuals with SARS-CoV-2 infection varied by gestational age
12. The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems
13. The HER2 I655V Polymorphism and Breast Cancer Risk in Ashkenazim
14. Development of the Initial Surveys for the All of Us Research Program
15. Neuroepigenomics: resources, obstacles, and opportunities
16. Thyroid Nodules, Polymorphic Variants in DNA Repair and RET-Related Genes, and Interaction with Ionizing Radiation Exposure from Nuclear Tests in Kazakhstan
17. Advancing translational science education.
18. A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health
19. An ontology-driven semantic mashup of gene and biological pathway information: Application to the domain of nicotine dependence
20. Symbiotic relationship of pharmacogenetics and drugs of abuse
21. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF
22. Setting Priorities for Genomic Research
23. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus
24. Genetic Research and Smoking Behavior
25. Candidate Single Nucleotide Polymorphism Selection using Publicly Available Tools: A Guide for Epidemiologists
26. Heterogeneity of rik for melanoma and pancreatic and digestive malignancies
27. Re: Population-Based, Case–Control Study of HER2 Genetic Polymorphism and Breast Cancer Risk
28. Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case–Control Study
29. Retinoid-Mediated Suppression of Tumor Invasion and Matrix Metalloproteinase Synthesis
30. Erratum: Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health (PLoS medicine (2018) 15 8 (e1002631))
31. POSTTRANSCRIPTIONAL REGULATION OF COLLAGENASE-1 GENE EXPRESSION IN SYNOVIOCYTES BY ADENOSINE RECEPTOR STIMULATION
32. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes
33. Diversity and inclusion for the All of Us research program: A scoping review.
34. The "All of Us" Research Program.
35. Community Resources and Technologies Developed Through the NIH Roadmap Epigenomics Program.
36. The Genetics of Addiction: A Global Problem with Global Opportunities.
37. Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: Evidence from 261 cases in Israel, 1976–1999
38. Re-definin G Addi C CH3 Tion: genomics and epigenomics on substance use disorders.
39. Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm.
40. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
41. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
42. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
43. Two approaches to mutation detection based on functional data.
44. Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium.
45. Human Metalloproteinase-1 (Collagenase-1) Is a Tumor Suppressor Protein p53 Target Gene.
46. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1β (IL-1β) in human fibroblasts and BC-8701 breast cancer cells.
47. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification.
48. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
49. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours.
50. Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.